ERBB2 and neoplasm: Using Her2 CAR T cells in an intracranial breast cancer metastasis model, Priceman and colleagues reported improved tumor eradication rates after intratumoral or intraventricular adoptive transfer [102], and Brown et al. showed no therapeutic effect at all for systemic intravenous injection [27].